Indoor Air Quality and Respiratory Symptoms in Former Smokers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02956213|
Recruitment Status : Completed
First Posted : November 6, 2016
Last Update Posted : June 13, 2019
|Condition or disease||Intervention/treatment||Phase|
|Chronic Obstructive Pulmonary Disease||Other: HEPA portable air filter Other: Sham Control/Active Comparator||Not Applicable|
This study will determine whether the presence of a portable high-efficiency indoor air filter in the bedroom improves respiratory symptoms (based on St. George's Respiratory Questionnaire - COPD - SGRQ-C score) during a period of high air pollution compared with placebo in former smokers with respiratory symptoms.
The primary outcome will be the change in SGRQ-C score associated with using a portable high-efficiency indoor air filter during the study period.
Secondary outcomes will assess the effect of using a portable high-efficiency indoor air filter on healthcare utilization, other symptom scores, COPD exacerbation frequency, medication use, median daily step counts, inflammatory markers, oxygenation, indoor particulate counts and indoor-outdoor particulate count difference, and pulmonary function tests.
Baseline descriptive statistics will report baseline air filter type, duration of use, and particulate weight prior to study enrollment.
Evaluation of change in symptom scores and other secondary outcomes from baseline to study air filter (Visit 1 vs. Visit 2).
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||52 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Assessing the Effect of Different Efficiency Indoor Air Filters on Respiratory Symptoms in Former Smokers|
|Study Start Date :||November 2016|
|Actual Primary Completion Date :||May 15, 2019|
|Actual Study Completion Date :||June 2019|
Experimental: ARM 1 MERV17 first
This group will receive a portable HEPA air filtering device with MERV17 air filter for the first part of the study. At cross over, this group will receive the "placebo" or no high-efficiency filter.
Other: HEPA portable air filter
A high efficiency (MERV17) portable air filter (HEPA portable air filter) will be placed in the subject's bedroom and will run 24/7 for the duration of the study.
Active Comparator: ARM 2 MERV17 second
This group will receive a HEPA portable air filter with no high efficiency air filter for the first part of the study. At cross over, this group will receive the high-efficiency MERV17 air filter.
Other: Sham Control/Active Comparator
A portable air filtering device will be placed with no high-efficiency air filter, but only the basic carbon filter in place. Then at cross over, there will be an active HEPA portable air filter used
- Change in SGRQ-C score [ Time Frame: 12 weeks ]based on St. George's Respiratory Questionnaire - COPD - SGRQ-C score
- Effect of air filtration on healthcare utilization [ Time Frame: 6 months ]Effect on COPD related ER visits and hospitalizations; CHF and MI related visits and hospitalizations and all cause ER visits and hospitalizations
- Aggregated assessment of the effect of air filtration on COPD exacerbation frequency [ Time Frame: 6 months ]A combined assessment of patient reported symptom questionnaires including increased medication use, ER visits and hospitalizations for breathing-related problems and COPD exacerbations. These assessments will be determined by patient reported hospitalizations/ED visits, and patient reported symptom increase and COPD-related medication changes.
- Change in median daily step counts [ Time Frame: 6 months ]Whether median daily step counts are affected by air pollution levels, or correlate with other metrics of COPD outcomes remains unknown and thus, step counts will be tracked.
- Change in inflammatory markers [ Time Frame: 6 months ]
This is a common office test used to assess how well the lungs work by measuring how much air the patients inhale, how much they exhale, and how quickly they exhale.
We will also perform pulse oximetry and a blood draw to assess inflammatory markers and basic labs.
COPD sufferers experience inflammation due to their disease. Inflammatory markers will be documented during their clinic visits.
- Change in spirometry [ Time Frame: 3 months ]Spirometry will be used to assess how well a subject's lungs work by measuring how much air is inhaled, how much is exhaled and how quickly you exhale. Spirometry is used to diagnose COPD and tracks it's progression or improve.
- Number of cardiovascular events [ Time Frame: 6 months ]CVA, MI, heart failure exacerbation
- Change in 6 minute walk test [ Time Frame: 3 months ]The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
- Change in sleep efficiency [ Time Frame: 12 weeks ]As measured by the activity tracker, the amount of hours slept
- Change in sleep quality [ Time Frame: 12 weeks ]As measured by the activity tracker, the number of disruptions in sleep
- Change in CAT scores [ Time Frame: 12 weeks ]COPD assessment test is a questionnaire used to determine subjective improve or progression of COPD.
- Change in mMRC scores [ Time Frame: 12 weeks ]Modified Medical Research Council Dyspnea Scale score used to track a subject's shortness of breath
- Change in other metrics of activity: specifically 6min walk distances and max walk distance [ Time Frame: 12 weeks ]walk distance
- Change in air filter changing habits [ Time Frame: 12 months ]Change in air filter changing habits
- Change in air filter weight with different filters (surrogate for particulates trapped) [ Time Frame: 12 months ]Change in air filter weight with different filters (surrogate for particulates trapped)
- Change in activity tracker use following study [ Time Frame: 12 months ]Question in 6 month follow up from study if participants bought their own step counter or if they already had a step counter, if they use the device more as a result of the study.
- Change in indoor particulate concentration as measured by personal air monitors (PurpleAir.org) [ Time Frame: 3 months ]Change in indoor particulate concentration as measured by personal air
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02956213
|United States, Utah|
|Intermountain Medical Center|
|Salt Lake City, Utah, United States, 84107|
|Principal Investigator:||Denitza Blagev, MD||Intermountain Health Care, Inc.|